C-proSP-B: A Possible Biomarker for Pulmonary Diseases?
Conclusions: SP-B pre-proteins might serve as a biomarker in pulmonary diseases with alveolar or interstitial damage such as ILDs, especially in IPF. Their role in the long-term monitoring of such diseases has to be clarified further.Respiration
Source: Respiration - Category: Respiratory Medicine Source Type: research
More News: Asthma | Cancer | Cancer & Oncology | Chronic Obstructive Pulmonary | Epithelial Cancer | Hypertension | Lung Cancer | Pulmonary Hypertension | Respiratory Medicine | Smokers | Study